Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Medicaid Work Requirements
  • ‘Skinny Labeling’
  • Gun Control
  • Suicide Prevention
  • Rural Health Payout

TRENDING TOPICS:

  • Medicaid Work Requirements
  • 'Skinny Labeling'
  • Gun Control
  • Suicide Prevention
  • Rural Health Payout

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Sep 14 2022

Full Issue

Perspectives: Antibiotic-Resistant Superbugs Are Particular Problem For Cancer Patients

Read recent commentaries about drug-cost issues.

The Baltimore Sun: Superbugs Need Their Own Moonshot Initiative 

For many cancer patients who die from this awful disease, their tumors aren’t solely responsible. In many instances, superbugs sicken these patients, who can’t fight off resistant infections due to weakened immune systems — even with the help of antibiotics. (Cynthia L. Sears and Fyza Shaikh, 9/12)

NBC News: Texas' PrEP Ruling Goes Against Common Sense HIV Prevention

An ounce of prevention is worth a pound of cure. As an HIV doctor in central Texas, I know that nowhere is that adage truer than in the case of pre-exposure prophylaxis (PrEP), a medication that is up to 99% effective at preventing HIV. A recent ruling in a Texas federal court has the potential to threaten not just PrEP but access to all commonsense preventive medical care for people in the U.S. (Dr. Aliza Norwood, 9/11)

Bloomberg: The FDA Is Rushing A New And Unproven ALS Drug 

A Food and Drug Administration advisory committee voted yesterday to recommend approval for an ALS drug being developed by Amylyx Pharmaceuticals. The fate of this small company’s drug could matter well beyond ALS to influence how data are regarded for other medicines. (Lisa Jarvis, 9/8)

Stat: Tackling The Next Drug Pricing Challenge 

The passage of the Inflation Reduction Act brings a new era to drug pricing in the United States. After decades of being an outlier, it now joins every other developed nation in having the federal government engaged in negotiating drug pricing. (Steve Pearson, 9/8)

Bloomberg: Insulin Prices Are Surging. Here's How Congress Can Rein Them In

Among the many crowd-pleasing elements of the Inflation Reduction Act, signed by President Joe Biden last month, is a measure that will cap the cost of insulin for Medicare recipients. (9/9)

Houston Chronicle: Greg Abbott Failed To ‘Eliminate Rape.’ His Plan B Isn’t Enough

If Abbott wanted to encourage more pharmacies and other stores to sell Plan B over the counter, he could direct the attorney general to clarify the legality of doing so since there seems to be so much confusion. (9/12)

Kansas City Star: Missouri, Kansas Opioid Crisis Demands New Approach And Laws 

The face of Ashton Harmon-Manser on a billboard hangs high above a busy strip of Interstate 70 in Kansas City because that’s where the 22-year-old died two years ago of an accidental overdose of fentanyl. (9/9)

Kansas City Star: Kansas And Missouri Senators Can Help Leave Outdated Animal Drug Testing In The Past

Our nation’s public-private partnership that has guided formulation, testing and delivery of drugs to patients — from cancer treatments to pain medications to neurological problems — is badly in need of a reboot. (David Wiebers, 9/10)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 30
  • Wednesday, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF